265 related articles for article (PubMed ID: 8545863)
1. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB
Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863
[TBL] [Abstract][Full Text] [Related]
2. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
[TBL] [Abstract][Full Text] [Related]
3. Long-term graft survival with or without donor-specific transfusion in cyclosporine era in one haplo-identical living-related renal transplant recipients beyond the first year: a 19-year experience.
Satoh S; Sugimura J; Omori S; Seino K; Fujizuka I
Tohoku J Exp Med; 2002 Aug; 197(4):201-7. PubMed ID: 12434995
[TBL] [Abstract][Full Text] [Related]
4. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
[TBL] [Abstract][Full Text] [Related]
5. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.
Sharma RK; Rai PK; Kumar A; Kumar P; Gupta A; Kher V; Agrawal S; Bhandari M
Nephron; 1997; 75(1):20-4. PubMed ID: 9031265
[TBL] [Abstract][Full Text] [Related]
6. Deoxyspergualin prophylaxis with tacrolimus further improves long-term graft survival in living-related renal-transplant recipients transfused with donor-specific blood.
Amada N; Okazaki H; Sato T; Ohashi Y; Kikuchi H
Transplant Proc; 2005 Mar; 37(2):927-9. PubMed ID: 15848577
[TBL] [Abstract][Full Text] [Related]
7. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
[TBL] [Abstract][Full Text] [Related]
8. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
Cecka JM
Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
[TBL] [Abstract][Full Text] [Related]
9. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy.
Salvatierra O; Melzer J; Potter D; Garovoy M; Vincenti F; Amend WJ; Husing R; Hopper S; Feduska NJ
Transplantation; 1985 Dec; 40(6):654-9. PubMed ID: 3907038
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal of steroid immunosuppression in renal transplant recipients.
Stratta RJ; Armbrust MJ; Oh CS; Pirsch JD; Kalayoglu M; Sollinger HW; Belzer FO
Transplantation; 1988 Feb; 45(2):323-8. PubMed ID: 3278423
[TBL] [Abstract][Full Text] [Related]
11. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens.
Leivestad T; Albrechtsen D; Flatmark A; Thorsby E
Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880
[TBL] [Abstract][Full Text] [Related]
12. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
[TBL] [Abstract][Full Text] [Related]
13. Mismatched living, related donor renal transplantation: a prospective, randomized study.
Sommer BG; Ferguson RM
Surgery; 1985 Aug; 98(2):267-74. PubMed ID: 3895539
[TBL] [Abstract][Full Text] [Related]
14. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
Leone MR; Alexander SR; Melvin T; Striegel J; Reller K; Norman DJ; Barry JM
J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
[TBL] [Abstract][Full Text] [Related]
15. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
Clark G; Walsh G; Deshpande P; Koffman G
Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
[TBL] [Abstract][Full Text] [Related]
17. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man.
Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O
Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251
[TBL] [Abstract][Full Text] [Related]
18. Renal transplantation from HLA-haploidentical living-related donors: the effects of donor-specific blood transfusions and different immunosuppressive regimens.
Sakagami K; Saito S; Shiozaki S; Fujiwara T; Haisa M; Niguma T; Kusaka S; Uda M; Matsuno T; Takasu S
Acta Med Okayama; 1992 Feb; 46(1):1-5. PubMed ID: 1561899
[TBL] [Abstract][Full Text] [Related]
19. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
Sumrani N; Delaney V; Ding ZK; Butt K; Hong J
Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
[TBL] [Abstract][Full Text] [Related]
20. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]